Clobazam
Back to searchMolecule Structure
Scientific Name
Clobazam
Description of the Drug
Clobazam is a benzodiazepine used as adjunct treatment in seizures associated with Lennox-Gastaut syndrome.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00349
http://www.drugbank.ca/drugs/DB00349
Brand Name(s)
Frisium, Onfi, Perizam, Sympazan, Tapclob, Urbanyl
Company Owner(s)
Alkem Laboratories Ltd, Aquestive Therapeutics Inc, Mylan Pharmaceuticals Inc, Amneal Pharmaceuticals Llc, Zydus Pharmaceuticals Usa Inc, Bionpharma Inc, Chartwell Molecular Holdings Llc, Micro Labs Ltd, Piramal Healthcare Uk Ltd, Upsher Smith Laboratories Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
GABA-A receptor; anion channel | PROTEIN COMPLEX GROUP | POSITIVE ALLOSTERIC MODULATOR | CHEMBL2093872 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL43038 | ||
PharmGKB | PA10888 | ||
Human Metabolome Database | HMDB0014493 | ||
DrugBank | DB00349 | ||
PubChem: Thomson Pharma | 15394984 | ||
PubChem | 2789 | ||
Nikkaji | J11.411A | ||
BindingDB | 50247888 | ||
EPA CompTox Dashboard | DTXSID2046759 | ||
DrugCentral | 682 | ||
Guide to Pharmacology | 7149 | ||
rxnorm | SYMPAZAN | CLOBAZAM | ONFI |
ChEBI | 31413 | ||
ZINC | ZINC000000001175 |